BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27826939)

  • 1. A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1
    Golko-Perez S; Amit T; Bar-Am O; Youdim MB; Weinreb O
    Neurotox Res; 2017 Feb; 31(2):230-244. PubMed ID: 27826939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1(G93A) Transgenic ALS Mice.
    Golko-Perez S; Amit T; Youdim MB; Weinreb O
    J Mol Neurosci; 2016 Aug; 59(4):504-10. PubMed ID: 27173029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Golko-Perez S; Mandel S; Amit T; Kupershmidt L; Youdim MB; Weinreb O
    Neurotox Res; 2016 Feb; 29(2):208-17. PubMed ID: 26581376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics.
    Varghese M; Zhao W; Trageser KJ; Pasinetti GM
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32414179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arctigenin derivative A-1 ameliorates motor dysfunction and pathological manifestations in SOD1
    Xiong B; Yang C; Yang X; Luo S; Li S; Chen C; He K; Nie L; Li P; Li S; Huang H; Liu J; Zhang Z; Xie Y; Zou L; Yang X
    CNS Neurosci Ther; 2024 Jun; 30(6):e14692. PubMed ID: 38872258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1α/Nrf2/HO-1 pathway in ALS mice.
    Wen J; Li S; Zheng C; Wang F; Luo Y; Wu L; Cao J; Guo B; Yu P; Zhang G; Li S; Sun Y; Yang X; Zhang Z; Wang Y
    Neuropharmacology; 2021 Jan; 182():108380. PubMed ID: 33152451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R13 preserves motor performance in SOD1
    Li X; Chen C; Zhan X; Li B; Zhang Z; Li S; Xie Y; Song X; Shen Y; Liu J; Liu P; Liu GP; Yang X
    Theranostics; 2021; 11(15):7294-7307. PubMed ID: 34158851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
    Yoo YE; Ko CP
    Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
    Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
    Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS.
    Thau N; Knippenberg S; Körner S; Rath KJ; Dengler R; Petri S
    J Neuropathol Exp Neurol; 2012 Dec; 71(12):1064-74. PubMed ID: 23147503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte Colony-Stimulating Factor Ameliorates Skeletal Muscle Dysfunction in Amyotrophic Lateral Sclerosis Mice and Improves Proliferation of SOD1-G93A Myoblasts in vitro.
    Rando A; Gasco S; de la Torre M; García-Redondo A; Zaragoza P; Toivonen JM; Osta R
    Neurodegener Dis; 2017; 17(1):1-13. PubMed ID: 27544379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis.
    Wang Q; Zhang X; Chen S; Zhang X; Zhang S; Youdium M; Le W
    Neurodegener Dis; 2011; 8(5):310-21. PubMed ID: 21346313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cromolyn sodium delays disease onset and is neuroprotective in the SOD1
    Granucci EJ; Griciuc A; Mueller KA; Mills AN; Le H; Dios AM; McGinty D; Pereira J; Elmaleh D; Berry JD; Paganoni S; Cudkowicz ME; Tanzi RE; Sadri-Vakili G
    Sci Rep; 2019 Nov; 9(1):17728. PubMed ID: 31776380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.
    Song W; Song Y; Kincaid B; Bossy B; Bossy-Wetzel E
    Neurobiol Dis; 2013 Mar; 51():72-81. PubMed ID: 22819776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice.
    Yoo YE; Ko CP
    PLoS One; 2012; 7(5):e37258. PubMed ID: 22606355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
    J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1
    Ionescu A; Gradus T; Altman T; Maimon R; Saraf Avraham N; Geva M; Hayden M; Perlson E
    Cell Death Dis; 2019 Mar; 10(3):210. PubMed ID: 30824685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.